Oncology Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes ... Researchers also dove into socio-economic disparities in cancer care.
Oncology New horizons in breast cancer care Interview with Markus Kosch, Daiichi Sankyo head of Oncology Business Division in Europe.
Oncology The challenges and opportunities for kidney cancer care reco... Kidney cancer care is rapidly approaching a tipping point in the UK.
Oncology Realising the promise of genomic testing across oncology Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world.
Oncology Diversity by design: the importance of DE&I in oncology tria... “First, do no harm”; is an ethical axiom at the heart of medical research; physicians worldwide pledge to uphold the oath to serve patients.
Oncology Phesi’s Dr Gen Li: New approaches to clinical trials in canc... Dr Gen Li, founder and president of Phesi, a provider of AI-powered clinical development analytics, products and solutions, discusses some of the latest challenges facing the industry, incl